Skip to content

Study on how add on varmam therapy Affects ocular parameters in people with refractive error

Effect of add-on varmam therapy on ocular parameters among individuals with refractive Error - A single-blinded pilot randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088365
Enrollment
24
Registered
2025-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H522- Astigmatism Health Condition 2: H520- Hypermetropia Health Condition 3: H521- Myopia

Interventions

Intervention1: Spectacles: Spectacles are the first line and standard management for refrative error Control Intervention1: Varmam Therapy: Participants will receive Varmam therapy sessions, administe

Sponsors

Division of Siddha Endowment fund, CIMR, MAHE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Individuals aged 18-35 years with diagnosed refractive errors (myopia, hyperopia, or astigmatism) of up to 6.00 dioptres. 2)No history of ocular surgery, trauma, or active ocular diseases. 3)Willingness to participate in Varmam therapy sessions.

Exclusion criteria

Exclusion criteria: 1)The presence of any systemic diseases affecting the eyes (e.g., diabetes). 2)Individuals undergoing other refractive treatments (e.g., LASIK) and other complementary therapies for eye health

Design outcomes

Primary

MeasureTime frame
Change in Refractive Error in DTimepoint: Baseline,first and sixth month

Secondary

MeasureTime frame
1)Change in Visual Acuity with Log MAR 2)Intra-ocular pressure in mmHg 3)Accommodation in D 4)Contrast sensitivity in log units Timepoint: Baseline,first and sixth month

Countries

India

Contacts

Public ContactJ Salai Dhavamathi

Division of Siddha, Centre for Integrative Medicine and Research (CIMR), MAHE,Manipal

arul.amuthan@manipal.edu9986353238

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026